Press release
Cytokine Market: A Holistic Expansion with Significant CAGR Forecasted for 2024-2031
Cytokine Market || 2024-2031
Get a Free Sample PDF - https://datamintelligence.com/download-sample/cytokine-market
What is the projected growth rate (CAGR) of the Global Cytokine market from 2024 to 2031, and what is the market value expected to change by 2031?
Global Cytokine Market reached US$ 72.3 billion in 2023 and is expected to reach US$ 132.2 billion by 2031, growing with a CAGR of 7.6 % during the forecast period 2021-2031.
What is Cytokine Market?
The cytokine market focuses on the research, development, and commercialization of cytokines, which are signaling proteins crucial for cell communication in the immune system. These proteins play a significant role in regulating immune responses and are essential in therapeutic applications for diseases like cancer, autoimmune disorders, and inflammatory conditions. The market is driven by increasing research in immunotherapy, advancements in biopharmaceuticals, and growing demand for targeted therapies. As healthcare providers seek innovative treatments, the cytokine market is experiencing robust growth, fostering new product developments and enhancing understanding of immune system dynamics.
Who are the major players in the Cytokine market?
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Cytokine market research report are: CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc, Sanofi, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd , Merck KGaA, GenScript and among others.
Key Development
On March 27, 2023, the U.S. Food and Drug Administration (FDA) approved CLN-617, a fusion protein developed by Cullinan Oncology, Inc. This innovative therapy combines two potent antitumor cytokines, IL-2 and IL-12, with a collagen binding domain designed for enhanced retention in the tumor microenvironment (TME) after intratumoral injection. The initial Phase 1 trial will evaluate CLN-617 in patients with advanced solid tumors.
On June 15, 2023, Genentech, a member of the Roche Group, announced that the FDA had approved Columvi (glofitamab-gxbm). This treatment is indicated for adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), including large B-cell lymphoma (LBCL) arising from follicular lymphoma, who have received two or more lines of systemic therapy.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=cytokine-market
Regions Covered:
The global Cytokine Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Market Segments
By Type: Chemokines, Interferons, Interleukins, Tumor necrosis factor (TNF), Monokines, Lymphokines, Colony-stimulating factors (CSF).
By Application: Cancer, Orthopedic, Dermatology, Others.
By End Users: Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Institutes, Others.
The Cytokine industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
➥ Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
➥ Meet critical unmet needs in complex conditions with advanced, precise Cytokine industry solutions for better diagnostics and outcomes.
➥ Stay ahead with real-time pipeline analysis, revealing the latest Cytokine innovations and market trends.
➥ Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
➥ Protect your innovation with expert patent analysis, ensuring strategic positioning in the Cytokine market.
➥ Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Cytokine
➥ Maximize market presence with brand share analysis, strengthening your position in the Cytokine landscape.
➥ Accurately predict market demand for Cytokine with precise drug sales forecasting insights.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/cytokine-market
FAQs
What does the Cytokine market report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
What is the scope of the market report?
The market report covers regional analysis and provides detailed insights into the Cytokine market including market size, segmentation, and key players.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cytokine Market: A Holistic Expansion with Significant CAGR Forecasted for 2024-2031 here
News-ID: 3706814 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Agricultural Micronutrients Market Set for Robust Growth as Farmer …
Market Size and Growth:
The Global Agricultural Micronutrients Market size reached USD 9,706 million in 2022 and is projected to witness lucrative growth by reaching up to USD 19,197 million by 2031. The market is expected to exhibit a CAGR of 9% during the forecast period (2024-2031).
The Agricultural Micronutrients Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth…
United States Telemedicine Market Set for Explosive Growth as Virtual Healthcare …
Market Size and Growth:
The Global Telemedicine Market size reached US$129.70 billion in 2024 and is expected to reach US$488.89 billion by 2033, growing at a CAGR of 16.8% during the forecast period 2025-2033
The Telemedicine Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these…
United States Clinical Trial Management System Market Set for Robust Growth with …
Market Size and Growth:
The Global Clinical Trial Management System Market size reached USD 1.5 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global clinical trial management system market is expected to exhibit a CAGR of 14.6% during the forecast period (2024-2031).
The Clinical Trial Management System Market report by DataM Intelligence provides insights into the latest trends and developments…
United States Healthcare Chatbots Market Set for Robust Growth as AI-Driven Pati …
Market Size and Growth:
The Healthcare Chatbots Market size reached US$ 823.96 Million in 2024 and is expected to reach US$ 5,692.97 Million by 2033, growing at a CAGR of 22.9% during the forecast period 2025-2033.
The Healthcare Chatbots Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to…
More Releases for Cytokine
Cytokine Release Syndrome Market New Product Development & Latest Trends
Introduction
Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by an excessive activation of the immune system, leading to a surge of pro-inflammatory cytokines. While CRS can occur in severe infections and autoimmune conditions, it has gained heightened significance as a common and potentially life-threatening complication of advanced immunotherapies, particularly chimeric antigen receptor T-cell (CAR-T) therapy, bispecific antibodies, and immune checkpoint inhibitors.
Symptoms range from fever, hypotension, and hypoxia to…
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Emerging Trends Influencing The Growth Of The Cytokine Release Syndrome Treatmen …
The Cytokine Release Syndrome Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Cytokine Release Syndrome Treatment Market Size Expected to Be by 2034?
The market size for the treatment of cytokine release syndrome has experienced remarkable growth recently. The market value…
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Key Driver Shaping the Future Cytokine Release Syndrome Treatment Market From 20 …
What Is the Estimated Market Size and Growth Rate for the Cytokine Release Syndrome Treatment Market?
In recent times, the market size for treatments of cytokine release syndrome has seen a rapid increase. The forecast predicts an upsurge from $1.25 billion in 2024 to $1.42 billion in 2025, presenting a compound annual growth rate (CAGR) of 13.7%. A growth surge during the historical period can be credited to factors such as…
Cytokine Market Size, Share, Growth Report and Forecast 2024-2032
According to the report by Expert Market Research (EMR), the global cytokine market is projected to grow at a CAGR of 6% between 2024 and 2032. Aided by the burgeoning applications in medical and research fields, the market is expected to grow significantly by 2032.
Cytokines are a broad category of small proteins that are crucial in cell signalling. Their role is primarily related to immune and inflammatory responses. These proteins…
